Medicare Enrolled
Dr. David Rahimian, D.O.
Vascular Neurology Physician · New Hyde Park, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rahimian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rahimian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rahimian
Dr. David Rahimian is a vascular neurology physician in New Hyde Park, NY, with 11 years of NPI registration. Based on federal Medicare data, Dr. Rahimian performed 3,077 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rahimian received a total of $11,687 from 60 pharmaceutical and/or device companies across 500 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rahimian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years of NPI registration
▲ Top 2% volume in NY
$11,687 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,077
Medicare services
Top 2% in NY for vascular neurology physician
Not available
Unique patients (not deduplicated)
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,059 | $72 | $91 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
567 | $118 | $154 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
420 | $153 | $206 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
327 | $108 | $138 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
284 | $74 | $94 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
173 | $195 | $245 |
| Emergency department visit, high complexity An emergency department visit involving a high level of medical decision making. |
95 | $158 | $203 |
| New patient office visit, complex (60-74 min) | 86 | $192 | $257 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
24 | $33 | $41 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
21 | $116 | $144 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
21 | $34 | $42 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,687
Total received (2021-2024)
Avg $2,922/year across 4 years
Top 20% in NY for vascular neurology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
500
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,556
2023
$3,066
2022
$2,165
2021
$1,900
Payments by company (2024)
ABBVIE INC.
$686
Alexion Pharmaceuticals, Inc.
$495
TG Therapeutics, Inc.
$396
PFIZER INC.
$362
SK Life Science, Inc.
$304
Lundbeck LLC
$256
AstraZeneca Pharmaceuticals LP
$165
ARGENX US, INC.
$158
Eisai Inc.
$154
Takeda Pharmaceuticals U.S.A., Inc.
$126
Amylyx Pharmaceuticals, Inc.
$125
DePuy Synthes Sales Inc.
$125
Alnylam Pharmaceuticals Inc.
$125
Neurocrine Biosciences, Inc.
$106
Amgen Inc.
$100
Genentech USA, Inc.
$89
Biogen, Inc.
$86
Otsuka America Pharmaceutical, Inc.
$72
SCILEX PHARMACEUTICALS INC.
$68
Chiesi USA, Inc.
$68
Merck Sharp & Dohme LLC
$61
Grifols USA, LLC
$50
Kyowa Kirin, Inc.
$49
Acorda Therapeutics, Inc
$44
Lilly USA, LLC
$41
Cumberland Pharmaceuticals, Inc.
$36
MDD US Operations, LLC
$35
Ipsen Biopharmaceuticals, Inc
$33
Boston Scientific Corporation
$28
EAGLE PHARMACEUTICALS, INC.
$27
CSL Behring
$21
Azurity Pharmaceuticals, Inc.
$20
Vanda Pharmaceuticals Inc.
$16
Novartis Pharmaceuticals Corporation
$15
ACADIA Pharmaceuticals Inc
$14
Top 3 companies account for 34.6% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,682
Alexion Pharmaceuticals, Inc.
$877
AbbVie Inc.
$747
Neurocrine Biosciences, Inc.
$731
SK Life Science, Inc.
$730
PFIZER INC.
$717
Lundbeck LLC
$708
TG Therapeutics, Inc.
$396
Takeda Pharmaceuticals U.S.A., Inc.
$315
ARGENX US, INC.
$291
Biogen, Inc.
$286
Chiesi USA, Inc.
$260
Horizon Therapeutics plc
$218
IMPEL PHARMACEUTICALS INC.
$214
AstraZeneca Pharmaceuticals LP
$211
EMD Serono, Inc.
$208
Cumberland Pharmaceuticals, Inc.
$200
Merck Sharp & Dohme LLC
$178
Grifols USA, LLC
$175
Eisai Inc.
$169
Amgen Inc.
$156
Lilly USA, LLC
$144
Alnylam Pharmaceuticals Inc.
$142
Penumbra, Inc.
$140
Mallinckrodt Hospital Products Inc.
$131
Amylyx Pharmaceuticals, Inc.
$125
DePuy Synthes Sales Inc.
$125
Kyowa Kirin, Inc.
$105
Biohaven Pharmaceutical Holding Company Ltd.
$96
Teva Pharmaceuticals USA, Inc.
$93
Corium, LLC
$93
Genentech USA, Inc.
$89
ACADIA Pharmaceuticals Inc
$87
Otsuka America Pharmaceutical, Inc.
$72
SCILEX PHARMACEUTICALS INC.
$68
Novartis Pharmaceuticals Corporation
$52
CATALYST PHARMACEUTICALS, INC.
$50
Avanir Pharmaceuticals, Inc.
$48
Acorda Therapeutics, Inc
$44
MITSUBISHI TANABE PHARMA AMERICA, INC.
$42
BANNER LIFE SCIENCES, LLC
$39
MDD US Operations, LLC
$35
Janssen Pharmaceuticals, Inc
$33
Ipsen Biopharmaceuticals, Inc
$33
Octapharma USA, Inc.
$30
Boston Scientific Corporation
$28
EAGLE PHARMACEUTICALS, INC.
$27
Xeris Pharmaceuticals, Inc.
$25
Merz Pharmaceuticals, LLC
$24
Supernus Pharmaceuticals, Inc.
$23
GENZYME CORPORATION
$22
CSL Behring
$21
Azurity Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme Corporation
$19
Neurelis, Inc.
$17
Celgene Corporation
$17
Mylan Specialty L.P.
$16
Vanda Pharmaceuticals Inc.
$16
EISAI INC.
$16
GE HealthCare
$13
Top 3 companies account for 28.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · BAFIERTAM · BARHEMSYS · BOTOX · BRIDION · BRILINTA · BRIUMVI · CALDOLOR · CLEVIPREX · Dysport · ELIQUIS · ELYXYB - CELECOXIB · EMGALITY · FIRDAPSE · GAMMAGARD · GAMMAGARD LIQUID · Gamunex-C · Glatiramer Acetate · Gocovri · HYQVIA · Hizentra · INBRIJA · INGREZZA · KENGREAL · KESIMPTA · KEVEYIS · KISUNLA · LEQEMBI · LUX-Dx Insertable Cardiac Monitor · Leqembi · MAVENCLAD · Mavenclad · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PONVORY · Penumbra System · QULIPTA · RADICAVA · RELYVRIO · REXULTI · SOLIRIS · Soliris · TYSABRI · Teligen · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · XCOPRI · Xeomin · ZEPOSIA · ZONISADE · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Vascular neurology physicians in nearby ZIP areas
49
County median income
$143,408
Nearest hospital to ZIP centroid (approximate)
LONG ISLAND JEWISH MEDICAL CENTER
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rahimian is a clinical cardiology specialist, with above-average Medicare volume (top 2% in NY).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rahimian experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Rahimian performed 1,059 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rahimian receive payments from pharmaceutical companies?
Yes. Dr. Rahimian received a total of $11,687 from 60 companies across 500 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rahimian's costs compare to other vascular neurology physicians in New Hyde Park?
Dr. Rahimian's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rahimian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Vascular Neurology Physicians in New Hyde Park
Browse vascular neurology physicians in New Hyde Park ranked by procedure volume and transparency data.
Highest volume
Top Vascular Neurology Physicians in NY
Vascular neurology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Vascular Neurology Physicians in NY
Which NY vascular neurology physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology